Raghav Goyal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Raghav Goyal has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- A. Simon Turner
Department of Veterinary Sciences, Colorado State University , Fort Collins, Colorado
1 shared publication - Aaron Watkins James
Department of Pathology, Johns Hopkins University, Baltimore, MD, USA
1 shared publication - Benjamin M. Wu
Department of Bioengineering, Department of Materials Science and Engineering, and Division of Advanced Prosthodontics, University of California, Los Angeles, Los Angeles, CA 90095, USA; Weintraub Center for Reconstructive Biotechnology, and Dental and Craniofacial Research Institute, School of Dentistry, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Orthopaedic Surgery, University of California, Los Angeles, Los Angeles, CA 90095, USA
1 shared publication - Chia Soo
Division of Plastic and Reconstructive Surgery, Department of Orthopaedic Surgery, Orthopaedic Hospital Research Center, University of California, Los Angeles, CA, USA
1 shared publication Choon G. Chung
Division of Growth and Development and Section of Orthodontics, Dental and Craniofacial Research Institute, School of Dentistry, University of California , Los Angeles, Los Angeles, California
1 shared publication- Greg Asatrian
Division of Growth and Development, Section of Orthodontics, School of Dentistry, University of California, Los Angeles, Los Angeles, CA 90095, USA
1 shared publication
Latest Publications
- Open Access
- 18 December 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
sisterless Ais required for activation ofSex lethalin theDrosophilagermline
Both somatic cells and germ cells must establish their correct sexual identity for proper gametogenesis. InDrosophila,sex determination in somatic cells is controlled by the switch geneSex lethal(Sxl), which is activated in females by the presence of two X chromosomes. Though germline sex determination is much less well understood,Sxlis also essential for the female identity in germ cells. Loss ofSxlfunction in the germline results in ovarian germline tumors, a characteristic of male germ cells developing in a female soma. Further,Sxlexpression is sufficient for XY (male) germ cells to produce eggs when transplanted into XX (female) somatic gonads. As in the soma, the presence of two X chromosomes activatesSxlin the germline, but the mechanism for “counting” X chromosomes in the germline is thought to be different from the soma. Here we have explored this mechanism at bothcis- andtrans-levels. Our data support the model that theSxl“establishment” promoter (SxlPE) is activated in a female-specific manner in the germline, as in the soma, but that the timing ofSxlPEactivation, and the DNA elements that regulateSxlPE,are different in the germline. Nevertheless, we find that the X chromosome genesisterless A (sisA),which helps activateSxlin the soma, is also essential forSxlactivation in the germline. Loss ofsisAleads causes of Sxl expression in the germline, and to ovarian tumors and germline loss. These defects can be rescued by Sxl expression, demonstrating thatsisAlies upstream ofSxlin germline sex determination. We conclude thatsisAacts as an X chromosome counting element in both the soma and the germline, but that additional factors regulating female-specific expression ofSxlin the germline remain to be discovered.AUTHOR SUMMARY: The production of sperm and eggs requires proper sexual identity to be established in both somatic cells and the germ cells, which ultimately produce the gametes. While somatic sex determination has been well studied in a number of organisms, how germ cells establish their sexual identity is much less well understood. In Drosophila, the RNA binding protein Sex lethal (Sxl) is essential for female sexual identity in both the soma and the germline, but its regulation in the germline is thought to be different than in the soma. Here we explore howSxlis activated in the germline. We find that the germline uses a different set of DNA elements to control activation of the key sex-specificSxlpromoter. Nonetheless, one of the activators ofSxlin the soma, the transcription factor Sisterless A (SisA), also acts to activateSxlin the germline. Our data indicate that, while SisA acts as a common activator in both the soma and germline, additional, germline-specificSxlactivators remain to be discovered.
- 18 December 2019
- Published by Cold Spring Harbor Laboratory in bioRxiv
Open Accesssisterless Ais required for activation ofSex lethalin theDrosophilagermline
Both somatic cells and germ cells must establish their correct sexual identity for proper gametogenesis. InDrosophila,sex determination in somatic cells is controlled by the switch geneSex lethal(Sxl), which is activated in females by the presence of two X chromosomes. Though germline sex determination is much less well understood,Sxlis also essential for the female identity in germ cells. Loss ofSxlfunction in the germline results in ovarian germline tumors, a characteristic of male germ cells developing in a female soma. Further,Sxlexpression is sufficient for XY (male) germ cells to produce eggs when transplanted into XX (female) somatic gonads. As in the soma, the presence of two X chromosomes activatesSxlin the germline, but the mechanism for “counting” X chromosomes in the germline is thought to be different from the soma. Here we have explored this mechanism at bothcis- andtrans-levels. Our data support the model that theSxl“establishment” promoter (SxlPE) is activated in a female-specific manner in the germline, as in the soma, but that the timing ofSxlPEactivation, and the DNA elements that regulateSxlPE,are different in the germline. Nevertheless, we find that the X chromosome genesisterless A (sisA),which helps activateSxlin the soma, is also essential forSxlactivation in the germline. Loss ofsisAleads causes of Sxl expression in the germline, and to ovarian tumors and germline loss. These defects can be rescued by Sxl expression, demonstrating thatsisAlies upstream ofSxlin germline sex determination. We conclude thatsisAacts as an X chromosome counting element in both the soma and the germline, but that additional factors regulating female-specific expression ofSxlin the germline remain to be discovered.AUTHOR SUMMARY: The production of sperm and eggs requires proper sexual identity to be established in both somatic cells and the germ cells, which ultimately produce the gametes. While somatic sex determination has been well studied in a number of organisms, how germ cells establish their sexual identity is much less well understood. In Drosophila, the RNA binding protein Sex lethal (Sxl) is essential for female sexual identity in both the soma and the germline, but its regulation in the germline is thought to be different than in the soma. Here we explore howSxlis activated in the germline. We find that the germline uses a different set of DNA elements to control activation of the key sex-specificSxlpromoter. Nonetheless, one of the activators ofSxlin the soma, the transcription factor Sisterless A (SisA), also acts to activateSxlin the germline. Our data indicate that, while SisA acts as a common activator in both the soma and germline, additional, germline-specificSxlactivators remain to be discovered.
- 1 June 2016
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 22 (11-12) , 840-849
Vertebral Implantation of NELL-1 Enhances Bone Formation in an Osteoporotic Sheep Model
Background: Vertebral compression fractures related to osteoporosis greatly afflict the aging population. One of the most commonly used therapy today is balloon kyphoplasty. However, this treatment is far from ideal and is associated with significant side effects. NELL-1, an osteoinductive factor that possesses both pro-osteogenic and anti-osteoclastic properties, and is a promising candidate for an alternative to current treatment modalities. The present study utilizes the pro-osteogenic properties of recombinant human NELL-1 (rhNELL-1) in lumbar spine vertebral defect model in osteoporotic sheep. Methods: Osteoporosis was induced through ovariectomy, dietary depletion of calcium and vitamin D, and steroid administration. After osteoporotic induction, lumbar vertebral body defect creation was performed. Sheep were randomly implanted with the control vehicle, comprised of hyaluronic acid (HA) with hydroxyapatite coated β-tricalcium phosphate (β-TCP), or the treatment material of rhNELL-1 protein lyophilized onto β-TCP mixed with HA. Analysis of lumbar spine defect healing was performed by radiographic, histologic, and computer simulated biomechanical testing. Results: RhNELL-1 treatment significantly increased lumbar spine bone formation, as determined by Bone Mineral Density (BMD), % Bone Volume (BV), and mean Cortical Width as assessed by micro-computed tomography. Histological analysis revealed a significant increase in Bone Area as well as osteoblast number and decrease in osteoclast number around the implant site. Computer-simulated biomechanical analysis of trabecular bone demonstrated that rhNELL-1-treatment resulted in a significantly more stress-resistant composition. Conclusion: Our findings suggest rhNELL-1 based vertebral implantation successfully improved cortical and cancellous bone regeneration in the lumbar spine of osteoporotic sheep. RhNELL-1 based bone graft substitutes represent a potential new local therapy.
- 1 June 2016
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 22 (11-12) , 840-849
Vertebral Implantation of NELL-1 Enhances Bone Formation in an Osteoporotic Sheep Model
Background: Vertebral compression fractures related to osteoporosis greatly afflict the aging population. One of the most commonly used therapy today is balloon kyphoplasty. However, this treatment is far from ideal and is associated with significant side effects. NELL-1, an osteoinductive factor that possesses both pro-osteogenic and anti-osteoclastic properties, and is a promising candidate for an alternative to current treatment modalities. The present study utilizes the pro-osteogenic properties of recombinant human NELL-1 (rhNELL-1) in lumbar spine vertebral defect model in osteoporotic sheep. Methods: Osteoporosis was induced through ovariectomy, dietary depletion of calcium and vitamin D, and steroid administration. After osteoporotic induction, lumbar vertebral body defect creation was performed. Sheep were randomly implanted with the control vehicle, comprised of hyaluronic acid (HA) with hydroxyapatite coated β-tricalcium phosphate (β-TCP), or the treatment material of rhNELL-1 protein lyophilized onto β-TCP mixed with HA. Analysis of lumbar spine defect healing was performed by radiographic, histologic, and computer simulated biomechanical testing. Results: RhNELL-1 treatment significantly increased lumbar spine bone formation, as determined by Bone Mineral Density (BMD), % Bone Volume (BV), and mean Cortical Width as assessed by micro-computed tomography. Histological analysis revealed a significant increase in Bone Area as well as osteoblast number and decrease in osteoclast number around the implant site. Computer-simulated biomechanical analysis of trabecular bone demonstrated that rhNELL-1-treatment resulted in a significantly more stress-resistant composition. Conclusion: Our findings suggest rhNELL-1 based vertebral implantation successfully improved cortical and cancellous bone regeneration in the lumbar spine of osteoporotic sheep. RhNELL-1 based bone graft substitutes represent a potential new local therapy.